This guideline describes the recommended protocols for detecting hemoglobinopathies and thalassemias by population-based newborn screening using dried blood spot specimens. Early, presymptomatic detection to identify newborns with abnormal hemoglobins is critical because it improves treatment effectiveness.
CLSI NBS08
Original price was: $180.00.$90.00Current price is: $90.00.
Newborn Screening for Hemoglobinopathies, 1st Edition, NBS08Ed1E
Clinical and Laboratory Standards Institute , 10/28/2019
Related products
-
CLSI EP18P2
Original price was: $121.00.$60.00Current price is: $60.00. -
CLSI LA01A2
Original price was: $180.00.$90.00Current price is: $90.00. -
CLSI C03-A4
Original price was: $110.00.$55.00Current price is: $55.00. -
CLSI M44-S2
Original price was: $190.00.$95.00Current price is: $95.00. -
CLSI H26A
Original price was: $295.00.$147.00Current price is: $147.00.